Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease
We're doing this study to learn if a haploidentical transplant is safe and effective to treat SCD.
The purpose of this study is to learn if a new type of allogeneic transplant called a haploidentical transplant is safe and effective to treat SCD.
Participants will be compensated for their participation.
- IRB Number: 1705650500
- Research Study Identifier: TX8197
- Principal Investigator: David Delgado, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required